Microbiology & Bacterial Culture for Industrial Testing
Microbiology & Bacterial Culture for Industrial Testing market is segmented by region (country), ... Read More
Global and United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size for the Year 2017-2028
1.2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size for the Year 2017-2028
1.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Dynamics
1.4.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Industry Trends
1.4.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
1.4.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
1.4.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Type
2.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment by Type
2.1.1 PCR
2.1.2 In-situ Hybridization
2.1.3 Immunohistochemistry
2.1.4 Sequencing
2.1.5 Others
2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017, 2022 & 2028)
2.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2028)
2.4 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017, 2022 & 2028)
2.5 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2028)
3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Application
3.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment by Application
3.1.1 Oncology
3.1.2 Neurological Disorders
3.1.3 Cardiovascular Disease
3.1.4 Immunological Disorders
3.1.5 Others
3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017, 2022 & 2028)
3.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2028)
3.4 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017, 2022 & 2028)
3.5 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2028)
4 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Competitor Landscape by Company
4.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Company
4.1.1 Top Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Ranked by Revenue (2021)
4.1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Player (2017-2022)
4.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Concentration Ratio (CR)
4.2.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in 2021
4.2.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Headquarters, Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Headquarters and Area Served
4.3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Company
4.5.1 Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2020, 2021 & 2022)
5 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region
5.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2028)
5.2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region: 2017-2022
5.2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.1.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.3.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.4.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Qiagen NV
7.1.1 Qiagen NV Company Details
7.1.2 Qiagen NV Business Overview
7.1.3 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.1.4 Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.1.5 Qiagen NV Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Details
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.2.4 GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.2.5 GE Healthcare Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Details
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.3.5 Agilent Technologies Recent Development
7.4 F Hoffman La Roche
7.4.1 F Hoffman La Roche Company Details
7.4.2 F Hoffman La Roche Business Overview
7.4.3 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.4.5 F Hoffman La Roche Recent Development
7.5 Foundation Medicine
7.5.1 Foundation Medicine Company Details
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.5.5 Foundation Medicine Recent Development
7.6 Thermo Fisher Scientific Inc.
7.6.1 Thermo Fisher Scientific Inc. Company Details
7.6.2 Thermo Fisher Scientific Inc. Business Overview
7.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.6.5 Thermo Fisher Scientific Inc. Recent Development
7.7 Leica Biosystems Nussloch GmBH
7.7.1 Leica Biosystems Nussloch GmBH Company Details
7.7.2 Leica Biosystems Nussloch GmBH Business Overview
7.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.7.5 Leica Biosystems Nussloch GmBH Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Details
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
7.8.4 Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
7.8.5 Pfizer Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Trends
Table 3. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
Table 4. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
Table 5. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
Table 6. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Player, 2017-2022
Table 13. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
Table 15. Top Players of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Qiagen NV Company Details
Table 31. Qiagen NV Business Overview
Table 32. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 33. Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 34. Qiagen NV Recent Development
Table 35. GE Healthcare Company Details
Table 36. GE Healthcare Business Overview
Table 37. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 38. GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 39. GE Healthcare Recent Development
Table 40. Agilent Technologies Company Details
Table 41. Agilent Technologies Business Overview
Table 42. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 43. Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 44. Agilent Technologies Recent Development
Table 45. F Hoffman La Roche Company Details
Table 46. F Hoffman La Roche Business Overview
Table 47. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 48. F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 49. F Hoffman La Roche Recent Development
Table 50. Foundation Medicine Company Details
Table 51. Foundation Medicine Business Overview
Table 52. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 53. Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 54. Foundation Medicine Recent Development
Table 55. Thermo Fisher Scientific Inc. Company Details
Table 56. Thermo Fisher Scientific Inc. Business Overview
Table 57. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 58. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 59. Thermo Fisher Scientific Inc. Recent Development
Table 60. Leica Biosystems Nussloch GmBH Company Details
Table 61. Leica Biosystems Nussloch GmBH Business Overview
Table 62. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 63. Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 64. Leica Biosystems Nussloch GmBH Recent Development
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 68. Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Picture
Figure 2. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2028 (US$ Million)
Figure 4. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2028 (US$ Million)
Figure 6. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share in Global 2017-2028
Figure 7. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Report Years Considered
Figure 8. Product Picture of PCR
Figure 9. Product Picture of In-situ Hybridization
Figure 10. Product Picture of Immunohistochemistry
Figure 11. Product Picture of Sequencing
Figure 12. Product Picture of Others
Figure 13. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type in 2022 & 2028
Figure 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
Figure 16. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type in 2022 & 2028
Figure 17. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
Figure 19. Product Picture of Oncology
Figure 20. Product Picture of Neurological Disorders
Figure 21. Product Picture of Cardiovascular Disease
Figure 22. Product Picture of Immunological Disorders
Figure 23. Product Picture of Others
Figure 24. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application in 2022 & 2028
Figure 25. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2028) & (US$ Million)
Figure 26. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
Figure 27. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application in 2022 & 2028
Figure 28. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2028) & (US$ Million)
Figure 29. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
Figure 30. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. U.S. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 34. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 40. China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. South Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Australia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Taiwan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Indonesia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Thailand Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Malaysia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Philippines Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Argentina Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 55. Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. U.A.E Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 58. Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 59. GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 60. Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 61. F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 62. Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 63. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 64. Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Qiagen NV GE Healthcare Agilent Technologies F Hoffman La Roche Foundation Medicine Thermo Fisher Scientific Inc. Leica Biosystems Nussloch GmBH Pfizer